Website profile

Biospace

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V

  • 281articles · 30d
  • 5+ hour agolatest article
  • Aug 17, 2026earliest in window
  • 91%with images
  • 289avg words
articles per day
Categories
  • Economy, Business & Finance 160
  • Health & Wellness 129
  • Medical 128
  • Business & Industrial 117
  • Finance & Business 105
  • Health 59
  • Science & Technology 48
  • Science & Nature 33

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

BioSpace
biospace.com > press-releases > neurelis-ceo-craig-chambliss-to-present-keynote-at-the-14th-annual-outsourcing-in-clinical-trials-southern-california-2026-conference

NEURELIS CEO CRAIG CHAMBLISS TO PRESENT KEYNOTE AT THE 14TH ANNUAL OUTSOURCING IN CLINICAL TRIALS SOUTHERN CALIFORNIA 2026 CONFERENCE

3+ day, 8+ hour ago   (319+ words) SAN DIEGO, Sept. 10, 2026 /PRNewswire/ -- Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced its Founder and Chief Executive Officer Craig Chambliss will give a keynote address at the 14th Annual Outsourcing Clinical Trials (OCT) Southern California 2026 conference, to be…...

BioSpace
biospace.com > press-releases > olympus-announces-new-class-of-itind-center-of-excellence-program-physicians

Olympus Announces New Class of iTind™ Center of Excellence Program Physicians

3+ day, 9+ hour ago   (457+ words) Program Aims to Advance Minimally Invasive Treatment of Enlarged Prostate CENTER VALLEY, Pa., Sept. 10, 2026 /PRNewswire/ -- Olympus Corp. of the Americas (Olympus) is pleased to announce the newest members of the iTind™ Center of Excellence (COE) Program, which is designed to…...

BioSpace
biospace.com > press-releases > innate-pharma-to-host-conference-call-and-webcast-on-september-17-for-first-half-2026-financial-results-and-business-update

Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update

4+ day, 34+ min ago   (133+ words) Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, September 17, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT, to provide a business update for the first…...

BioSpace
biospace.com > press-releases > apollomd-welcomes-scott-oneil-to-strategic-advisory-board

ApolloMD Welcomes Scott O’Neil to Strategic Advisory Board

3+ day, 21+ hour ago   (158+ words) Healthcare executive joins board as ApolloMD brings industry leaders together to explore the future of healthcare “Healthcare continues to evolve quickly, and having diverse perspectives at the table helps us think differently about what comes next,” said Yogin Patel, MD,…...

Google News
biospace.com > press-releases > puma-biotechnology-to-present-at-h-c-wainwrights-28th-annual-global-investment-conference

Puma Biotechnology to Present at H.C. Wainwright???s 28th Annual Global Investment Conference

4+ day, 11+ hour ago   (391+ words) Puma Biotechnology to Present at H.C. Wainwright’s 28th Annual Global Investment Conference BioSpace Puma Biotechnology to Present at H.C. Wainwright’s 28th Annual Global Investment Conference LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman,…...

BioSpace
biospace.com > press-releases > immunogenesis-announces-appointment-of-reza-mazhari-and-mike-davis-to-its-board-of-directors

ImmunoGenesis Announces Appointment of Reza Mazhari and Mike Davis to Its Board of Directors

4+ day, 9+ hour ago   (503+ words) BioSpace ImmunoGenesis Announces Appointment of Reza Mazhari and Mike Davis to Its Board of Directors HOUSTON, Sept. 9, 2026 /PRNewswire/ -- ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, announces the appointment of Reza Mazhari, Ph.D., and Mike Davis to its Board…...

BioSpace
biospace.com > press-releases > latus-bio-appoints-donald-hayden-as-chairman-of-the-board-and-michael-maclean-as-independent-director-and-audit-committee-chair

Latus Bio Appoints Donald Hayden as Chairman of the Board and Michael MacLean as Independent Director and Audit Committee Chair

4+ day, 22+ hour ago   (626+ words) BioSpace Latus Bio Appoints Donald Hayden as Chairman of the Board and Michael MacLean as Independent Director and Audit Committee Chair Bristol Myers Squibb and seasoned biotechnology veteran Donald Hayden, M.B.A., appointed as Chairman of the Latus Board of Directors Former…...

BioSpace
biospace.com > press-releases > trialbee-to-present-with-takeda-showcase-ai-for-clinical-sites-and-unveil-ai-powered-patient-screening-at-dpharm-2026

Trialbee to Present with Takeda, Showcase AI for Clinical Sites, and Unveil AI-Powered Patient Screening at DPHARM 2026

4+ day, 19+ hour ago   (263+ words) Trialbee continues to bring fresh innovation to clinical trials with its Honey Platform™, demonstrating how AI is reshaping patient recruitment – and where it goes from here MALMO, Sweden & WILMINGTON, Del.--(BUSINESS WIRE)--Trialbee, the global patient recruitment leader reimagining clinical…...

BioSpace
biospace.com > press-releases > alto-neuroscience-announces-participation-in-upcoming-september-2026-investor-conferences

Alto Neuroscience Announces Participation in Upcoming September 2026 Investor Conferences

4+ day, 20+ hour ago   (237+ words) BioSpace Alto Neuroscience Announces Participation in Upcoming September 2026 Investor Conferences MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--$anro #cns--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced…...

BioSpace
biospace.com > press-releases > twist-bioscience-to-present-at-baird-2026-global-healthcare-conference

Twist Bioscience to Present at Baird 2026 Global Healthcare Conference

4+ day, 20+ hour ago   (265+ words) BioSpace Twist Bioscience to Present at Baird 2026 Global Healthcare Conference SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience,…...